Biomarkers of Bone Turnover Can Be Assayed from Human Saliva

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 59, Issue 3, 2004, Pages 196-200

  McGehee Jr , John W ^a   Johnson, Roger B ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DEOXYPYRIDINIUM; OSTEOCALCIN; PYRIDINIUM DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; BODY MASS; BONE DENSITY; BONE MINERAL; BONE TURNOVER; CALCANEUS; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FACTORIAL ANALYSIS; FEMALE; HUMAN; MASS SCREENING; METABOLIC BONE DISEASE; NORMAL HUMAN; OSTEOPOROSIS; OVARIECTOMY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SALIVA ANALYSIS; SCORING SYSTEM; SHEEP; T SCORE; TUKEY TEST; VARIANCE;

OVIS ARIES;

EID: 1642304973     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/59.3.b196     Document Type: Article

References (58)

1. Riggs BL, Melton LJ. The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone. 1995;17(5 Suppl.):505S-511S.
2. Mattson JS, Cerutis DR, Parrish LC. Osteoporosis: a review and its dental implications. Compend Contin Educ Dent. 2002;23:1001-1013.
3. Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9:1137-1141.
4. National Institute of Arthritis, Musculoskeletal and Skin Diseases. 2000. Access at: http://www.nih.gov/niams/healthinfo/opbkr.htm
5. Daniell HW. Osteoporosis of the slender smoker: vertebral compression fractures and loss of metacarpal cortex in relation to postmenopausal cigarette smoking and lack of obesity. Arch Intern Med. 1976;136:298-304.
6. Ribot C, Tremollieres F, Pouilles J-M, et al. Obesity and postmenopausal bone loss: the influence of obesity on vertebral density and bone turnover in postmenopausal women. Bone. 1988;8:327-331.
7. Manolagas SC, Bellido T, Jilka RL. Sex steroids, cytokines and the bone marrow: new concepts on the pathogenesis of osteoporosis. Ciba Found Symp. 1995;191:187-196.
8. Gardsell P, Johnell O, Nilsson BE, et al. The predictive value of bone loss for fragility fractures in women: a longitudinal study over 15 years. Calcif Tissue Int. 1991;49:90-94.
9. Mazess RB, Barden HS. Measurement of bone by dual-photon absorptiometry (DPA) and dual-energy X-ray absorptiometry (DEXA). Ann Chir Gynaecol. 1988;77:197-203.
10. Salamone LM, Krall EA, Harris S, Dawson-Hughes B. Comparison of broadband ultrasound attenuation to single X-ray absorptiometry measurements at the calcaneus in postmenopausal women. Calcif Tissue Int. 1994;54:87-90.
11. Phillipov G, Phillips PJ. Skeletal site bone mineral density heterogeneity in women and men. Osteoporos Int. 2001;12:362-365.
12. Lu K, Gemant HK, Shepard J, et al. Classification of osteoporosis based on bone mineral densities. J Bone Miner Res. 2001;5:901-910.
13. Kim KI, Han IK, Kim H, Cho NH. How reliable is the ultrasound densitometer for community screening to diagnose osteoporosis in spine, femur and forearm. J Clin Densitom. 2001;4:159-165.
14. Nairus J, Ahmadi S, Baker S, Baran D. Quantitative ultrasound: an indicator of osteoporosis in perimenopausal women. J Clin Densitom. 2000;3:141-147.
15. Narayanan AS, Page RC. Connective tissues of the periodontium: a summary of current work. Collagen Rel Res. 1983;3:33-64.
16. Last JA, Armstrong LG, Reiser KM. Biosynthesis of collagen crosslinks. Int J Biochem. 1990;22:559-564.
17. Eriksen EF, Charles P, Melsen F, et al. Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. J Bone Miner Res. 1993;8:127-132.
18. Eastell R, Robins SP, Colwell T, Assiri AM, et al. Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption. Osteoporos Int. 1993;3:255-260.
19. Lian JB, Gundberg CM. Osteocalcin. Biochemical considerations and clinical applications. Clin Orthop. 1988;226:267-291.
20. Brown JP, Delmas PD, Malaval L, et al. Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet. 1984;1:1091-1093.
21. Gamero P, Delmas PD. Biochemical markers of bone turnover. Applications for osteoporosis. Endocrinol Metab Clin North Am. 1998;27:303-323.
22. Yilmaz N, Bayram M, Erbagci AB, Kilincer MS. Diagnostic value of biochemical markers of bone turnover and postmenopausal osteoporosis. Clin Chem Lab Med. 1999;37:137-143.
23. Johnson RB, Gilbert JA, Cooper RC, et al. Effect of estrogen deficiency on skeletal and alveolar bone density in sheep. J Periodontol. 2002;73:383-391.
24. Norderyd OM, Grossi SG, Machtei EE, et al. Periodontal status of women taking postmenopausal estrogen supplementation. J Periodontol. 1993;64:957-962.
25. Reinhardt RA, Payne JB, Maze CA, et al. Influence of estrogen and osteopenia/osteoporosis on clinical periodontitis in postmenopausal women. J Periodontol. 1999;70:823-828.
26. Streckfus CF, Johnson RB, Nick TG, Tsao A, Tucci M. Comparison of alveolar bone loss, alveolar bone density and second metacarpal bone density, salivary and gingival crevicular fluid interleukin-6 concentrations in healthy premenopausal and postmenopausal women on estrogen therapy. J Gerontol Biol Sci Med Sci. 1997;52A:M343-M351.
27. Groen JJ, Menczel J, Shapiro S. Chronic destructive periodontal disease in patients with presenile osteoporosis. J Periodontol. 1968;39:19-23.
28. Kribbs PJ, Smith DE, Chesnut CH. Oral findings in osteoporosis. Part II: Relationship between residual ridge and alveolar bone resorption and generalized skeletal osteopenia. J Prosthet Dent. 1983;50:719-724.
29. Kribbs PJ, Chesnut CH, Ott SM, Kilcoyne RF. Relationships between mandibular and skeletal bone in an osteoporotic population. J Prosthet Dent. 1989;62:703-707.
30. von Wowern N, Klausen B, Kollerup G. Osteoporosis: a risk factor in periodontal disease. J Periodontol. 1994;65:1134-1138.
31. Becker AR, Handick KE, Roberts WE, Garetto LP. Osteoporosis risk factors in female dental patients. A preliminary report. J Indiana Dent Assoc. 1997;76:15-19.
32. Persson RE, Persson GR, Kiyak HA, Powell LV. Oral health and medical status in dentate low-income older persons. Spec Care Dent. 1998;18:70-77.
33. Payne JB, Reinhardt RA, Nummikoski P, Patil KD. Longitudinal alveolar bone loss in postmenopausal osteoporotic/osteopenic women. Osteoporos Int. 1999;10:34-40.
34. Taguchi A, Tanimoto K, Suei Y, Otani K, Wada T. Oral signs as indicators of possible osteoporosis in elderly women. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;80:612-616.
35. Taguchi A, Tanimoto K, Suei Y, Wada T. Tooth loss and mandibular osteopenia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79:127-132.
36. Birkenfeld L, Yemini M, Kase NG, Birkenfeld A. Menopause-related oral alveolar bone resorption: a review of relatively unexplored consequences of estrogen deficiency. Menopause. 1999;6:129-133.
37. Persson RE, Hollender LG, Powell LV, et al. Assessment of periodontal conditions and systemic disease in older subjects. I. Focus on osteoporosis. J Clin Periodontol 2002;29:796-802.
38. Johnson RB, Gilbert JA, Cooper RC, et al. Alveolar bone loss one year following ovariectomy in sheep. J Periodontol. 1997;68:864-871.
39. Mohajery M, Brooks SL. Oral radiographs in the detection of early signs of osteoporosis. Oral Surg Oral Med Oral Pathol. 1992;73:112-117.
40. Hildebolt CF. Osteoporosis and oral bone loss. Dentomaxillofac Radiol. 1997;26:3-15.
41. Navazesh M, Christensen CM. A comparison of whole mouth resting and stimulated salivary measurement procedures. J Dent Res. 1982;61:1158-1162.
42. Chung KW, Kim MR, Yoo SW, et al. Can bone turnover markers correlate bone mass at the hip and spine according to menopausal period? Arch Gynecol Obstet. 2000;264:119-123.
43. Speden DJ, Calin AI, Ring FJ, Bhalla AK. Bone mineral density, calcaneal ultrasound, and bone turnover markers in women with ankylosing spondylitis. J Rheumatol. 2002;29:516-521.
44. Peichl P, Griesmacherb A, Marteau R, et al. Serum crosslaps in comparison to serum osteocalcin and urinary bone resorption markers. Clin Biochem. 2001;34:131-139.
45. Garnero P, Somay-Rendu E, Duboeuf F, Delmas PD. Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: the OFELY study. J Bone Miner Res. 1999;19:1614-1621.
46. Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286:1195-1200.
47. Wood N, Johnson RB, Streckfus CF. Comparison of body composition and periodontal disease using nutritional assessment techniques: Third National Health and Nutrition Examination Survey (NHANES). J Clin Periodontol. 2003;30:321-327.
48. Sypniewska G, Chodakowska-Akolinska G. Bone turnover markers and estradiol level in postmenopausal women. Clin Chem Lab Med. 2000;38:1115-1119.
49. Souberbielle JC, Cormier C, Kindermans C. Bone markers in clinical practice. Curr Opin Rheumatol. 1999;11:312-319.
50. Klemetti E, Vaino P. Effect of bone mineral density in skeleton and mandible on extraction of teeth and clinical alveolar height. J Prosthet Dent. 1993;70:21-25.
51. Wactawski-Wende J, Grossi SG, Trevisan M, et al. The role of osteopenia in oral bone loss and periodontal disease. J Periodontol. 1996;67(10 Suppl):1076-1084.
52. Jacobs R, Ghyselen J, Koninclx P, van Steenberghe D. Long-term bone mass evaluation of mandible and lumbar spine in a group of women receiving hormone replacement therapy. Eur J Oral Sci. 1996;104:10-16.
53. Loza JC, Carprio LC, Dziak R. Osteoporosis and its relationship to oral bone loss. Curr Opin Periodontol. 1996;3:27-33.
54. Krejci CB. Osteoporosis and periodontal disease: is there a relationship? J West Soc Periodontol Abstr. 1996;44:37-42.
55. Kelm RJ. Colorimetric immunoassay for native osteocalcin [Abstract]. J Bone Miner Res. 1992;7(1 Suppl):S263.
56. Seyedin SM, Kung VT, Daniloff YN, et al. Immunoassay for urinary pyridinoline: the new marker of bone resorption. J Bone Miner Res. 1993;8:635-641.
57. De Leo V, Ditto A, la Marca A, et al. Bone mineral density and biochemical markers of bone turnover in peri- and postmenopausal women. Calcif Tissue Int. 2000;66:263-267.
58. Ravin P, Clemmesen B, Christiansen C. Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women. Bone. 1999;24:237-244.